gvtcx

Vagal Nerve Stimulator (VNS)

NWSSP Cardiff and Vale Local Health Board Published 23 Jan 2024 Sell2Wales

key details

Statuscomplete
Category (CPV) 33158210
Procedurelimited
OCIDocds-h6vhtk-03a5a5

Award

SupplierValueDateStatus
LivaNova UK Ltd · · active

description

The Neurosciences department within Cardiff and Vale Local Health Board currently perform Vagal Nerve Stimulator (VNS) therapy. VNS therapy is delivered through an implanted device that sends mild pulses to the vagus nerve at regular intervals throughout the day in an effort to reduce and/or prevent seizures. Patients are referred to this type of therapy when drugs have failed to provide a more manageable treatment. These devices are programmable for a personalised therapy approach and the technology is highly specialised.

Currently Livanova hold the monopoly of the global market for VSN products as they hold the patent for the manufacture and production of these stimulators, therefore the Health Board are proposing to award a two year contract.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
14 Feb 2023 Voluntary ex-ante transparency (F15) Earlier regulations 004559-2023
23 Jan 2024 Contract award notice (F03) Earlier regulations 002248-2024

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Sell2Wales. Contact details for named individuals are not reproduced on this site.